Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$377K Buy
1,041
+83
+9% +$28.4K 0.02% 117
2026
Q1
$337K Buy
958
+206
+27% +$73.4K 0.02% 100
2025
Q4
$246K Hold
752
0.01% 95
2025
Q3
$212K Hold
752
0.01% 100
2025
Q2
$210K Sell
752
-4
-0.5% -$1.13K 0.01% 102
2025
Q1
$236K Buy
+756
New +$223K 0.02% 98
2024
Q4
Sell
-752
Closed -$242K 133
2024
Q3
$242K Sell
752
-42
-5% -$13.7K 0.02% 93
2024
Q2
$248K Hold
794
0.02% 96
2024
Q1
$226K Buy
794
+48
+6% +$14K 0.02% 93
2023
Q4
$215K Hold
746
0.02% 91
2023
Q3
$200K Buy
+746
New +$186K 0.02% 96

Other funds holding AMGN

Greenwood Gearhart's AMGN Position: Q2 2026 in Review

Greenwood Gearhart increased its Amgen (AMGN) stake by 8.7% in Q2 2026, buying an estimated $28.4K and bringing the position to 1,041 shares worth $377K. The position accounts for 0.02% of the portfolio, ranked #117.

Greenwood Gearhart first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Greenwood Gearhart held 1,041 shares of Amgen worth $377K as of Q2 2026.
  • Greenwood Gearhart bought 83 Amgen shares in Q2 2026, an estimated $28.4K.
  • Amgen made up 0.02% of Greenwood Gearhart's portfolio in Q2 2026, its #117 holding.
  • Greenwood Gearhart first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Greenwood Gearhart's 13F filing for Q2 2026, filed 24 Jul 2026.